References
- Filip M, Frankowska M, Zaniewska M, Golda A, Przegalinski E. The serotonergic system and its role in cocaine addiction. Pharmacol Rep 2005;57:685-700.
- Sun L, Lau CE. Simultaneous pharmacokinetic modeling of cocaine and its metabolites, norcocaine and benzoylecgonine, after intravenous and oral administration in rats. Drug Metab Dispos 2001;29:1183-9.
- Arinc E, Bozcaarmutlu A. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver. J Biochem Mol Toxicol 2003;17:169-76.
- Liu XQ, Ren YL, Qian ZY, Wang GJ. Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes. Acta Pharmacol Sin 2000;21:690-4.
- Vetulani J. Calcium and voltage-dependent calcium channels. Kismos 1997;46:491-505.
- etulani J. Drug addiction. Part III. Pharmacotherapy of addiction. Pol J Pharmacol 2001;53:415-35.
- Vitcheva V, Mitcheva M. Effects of Nifedipine on behavioral and biochemical parameters in rats after multiple morphine administration. Methods Find Exp Clin Pharmacol 2004;26:631-4.
- Council of Europe. European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes. CETS No. 123, 1991. [displayed 30 May 2007] Available at http://conventions.coe.int/Treaty/Commun/QueVoulezVous.asp?NT=123&CM=1&CL=ENG
- Antkiewicz-Michaluk L, Romanska I, Vetulani J. Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism. Eur J Pharmacol 1997;332:9-14.
- Itzhak Y, Ali SF, Martin JL, Black MD, Huang PL. Resistance of neuronal nitric oxide synthase-deficient mice to cocaine-induced locomotor sensitization. Psychopharmacol 1998;140:378-86.
- Bhagwat SV, Boyd MR, Ravindranath V. Rat brain cytochrome P 450. Reassessment of monooxygenase activities and cytochrome P450 levels. Drug Metab Disps 1995;23:651-4.
- Guengerich FP. Microsomal enzymes involved in toxicology. Analysis and separation. In: Heis AW, editor. Principals and Methods of Toxicology. New York (NY): Raven Press; 1987. p. 609-634.
- Omura T, Sato R. The carbon-monoxide-binding pigment of liver microsomes. J Biol Chem 1964;239:2370-85.
- Lowry OH. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
- Antkiewicz-Michaluk L, Michaluk J, Romanska I, Vetulani J. Reduction of morphine dependence and potenciation of analgesia by co-administration of nifedipin. Biopharmacol 1993;111:457-67.
- Watson WP, Little JJ. Effects of dihydropiridines on the components of the ethanol withdrawal syndrome: possible evidence for involvement of potassium, as well as calcium? Alcohol Clin Exp Res 1997;21:409-16.
- Haward LA, Sellers EM, Tyndale RF. The role of pharmacogenetically - variable cytochrome P450 in drug abuse and dependence. Pharmacogenomics 2002;3:185-99.
- Koleva MR, Stoychev TS. Effect of nifedipine, verapamil and diltiazem on the enzyme-inducing activity of phenobarbital and beta-naphthoflavone. Gen Pharmacol 1995;26:225-8.
- Kastelova A, Koleva M, Staneva-Stoytcheva D. Changes in rat liver monooxygenase activities after administration of atenolol, nifedipine and diltiazem alone and in combination. Methods Find Exp Clin Pharmacol. 2000;22:627-31.
- Shuster L, Garhart C, Powers J, Grunfeld Y, Kanel G. Hepatotoxicity of cocaine. NIDA Res Monogr 1988;88:250-75.
- Powers JF, Shuster L. Subacute cocaine treatment changes expression of mouse liver cytochrome P450 isoforms. Pharmacology 1999;58:87-100.
- Pasanen M, Pellinen P, Stenback F, Juvonen RO, Raunio H, Pelkonen O. The role of CYP enzymes in cocaineinduced liver damage. Arch Toxicol 1995;69:287-90.
- Nabeshima T, Fontenit J, Ho IK. Effect of chronic administration of phenobarbital or morphine on the brain micrisomal cytochrome P450 system. Biochem Pharmacol 1981;30:1142-5.